In this study, we are comparing different doses of CT-868 to placebo to learn more about its effectiveness in decreasing Hemoglobin A1C and in decreasing weight in people with Type 1 diabetes who are overweight or obese.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Klara Klein
Medicine-Endocrinology
Clinical or Medical
Interventional
Diabetes
23-1480